本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Can-Fite Biopharma Ltd

1.22
+0.02001.67%
成交量:16.95萬
成交額:20.74萬
市值:1,568.08萬
市盈率:-1.12
高:1.24
開:1.23
低:1.22
收:1.20
資料載入中...
2019/06/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2019/05/24

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

招股説明書

Registration statement for certain foreign private issuers
2019/05/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

[修訂]年度報告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/28

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/20

SEC問詢函

[Cover]Correspondence
2019/03/12

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers